EP
CGEN icon

Essential Partners’s Compugen CGEN Stock Holding History

Essential Partners’s Portfolio CGEN Stock Details CGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-146
Closed -$223 – 2871
2025
Q4 		$223 Hold
146
– – ﹤0.01% 2410
2025
Q3 		$215 Hold
146
– – ﹤0.01% 2390
2025
Q2 		$260 Buy
+146
New +$217 ﹤0.01% 1877

Other funds holding CGEN

SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $527M AUM 50.16% 1-Year Est. Return

Essential Partners's CGEN Position: Q1 2026 in Review

Essential Partners sold out of Compugen (CGEN) in Q1 2026, closing a stake of 146 shares — an estimated $223 sold.

Essential Partners first reported a position in CGEN in Q2 2025 and held it in 3 quarters. The position peaked at $260 in Q2 2025. 79 funds tracked by Wall St. Rank hold CGEN as of Q1 2026.

  • Essential Partners reported no remaining Compugen position as of Q1 2026 after selling out during the quarter.
  • Essential Partners sold 146 Compugen shares in Q1 2026, an estimated $223.
  • Essential Partners first reported a position in Compugen in Q2 2025 and held it in 3 quarters.
  • Essential Partners's Compugen position peaked at $260 in Q2 2025.
  • 79 funds tracked by Wall St. Rank held Compugen as of Q1 2026.

Based on Essential Partners's 13F filing for Q1 2026, filed 21 May 2026.